Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) agreed to acquire 18.7751% stake in Runsheng Pharmaceutical Co., Ltd. from Chongqing Boyi Xintian Equity Investment Fund Partnership Enterprise (Limited Partnership) managed by Tasly Capital and Chongqing Juxin Investment Co., Ltd. for CNY 58.9 million on January 4, 2024. The consideration consists of CNY 58.91 million in cash. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. board of directors approved the transaction.